Epidemiologist | Diabetes | Hypoglycemia | Assistant Prof @UofMaryland | Adjunct Prof @WesternU | @IHSGOnline Vice Chair | 🇹🇹🇨🇳🇩🇪🇨🇦🏳️🌈
The DMV, United States
Joined September 2021
- Tweets692
- Following770
- Followers1.7K
- Likes964
Alexandria Ratzki-LeeWing, PhD retweeted
Level 3 #hypoglycaemia remains common in #diabetes!. @AlexR_L and team demonstrate Real‐world incidence and risk factors of level 3 (severe) hypo: dom-pubs.onlinelibrary.wiley…
Alexandria Ratzki-LeeWing, PhD retweeted
A reminder to all healthcare professionals
#T1Diabetes can present at ANY age
Approximately 2/3 are diagnosed by age 30- and 1/3 thereafter
Don't presume #Type
Data via @DiabetesAudit
@Jazzsethi95 @drmohanv @kamleshkhunti
Alexandria Ratzki-LeeWing, PhD retweeted
Management and Medical Care for Individuals with Type 1 Diabetes Running a Marathon - goo.gl/scholar/ryFmNY #ScholarAlerts
Alexandria Ratzki-LeeWing, PhD retweeted
An inspiration to so many!! Congratulations @profmjdavies. So very very well deserved! 🥰
Congratulations to Prof Melanie J. Davies, the 2025 Outstanding Achievement in Clinical Diabetes Research Awardee, for exceptional contributions in patient-oriented clinical outcomes research with significant impact on diabetes prevention and treatment diabetes.org/newsroom/press-…
Alexandria Ratzki-LeeWing, PhD retweeted
I need people to understand how difficult it is to get an NIH grant. You spend months writing a proposal, following strict guidelines that include a detailed multiyear budget, bios of everyone on your team, plans for participant safety & ethical conduct. Then you send it off -1/n
Alexandria Ratzki-LeeWing, PhD retweeted
VX-880, stem cell derived islet therapy from @VertexPharma is going into phase 3 study. A big step towards cure of #type1diabetes but it still requires immunosuppressive drugs.
Breakthrough Update: Today, Vertex announced that they are beginning their Phase 3, or pivotal trial for VX-880, a stem cell-derived islet therapy. A pivotal trial gathers the data required for an FDA submission. This therapy is for people with type 1 diabetes (T1D) and hypoglycemia unawareness and severe hypoglycemic episodes.
This is a HUGE first for the #T1D community as it is the first time a scalable cure for some people with T1D is entering this phase.
Breakthrough T1D and the T1D Fund are incredibly proud to have supported this work in cell therapies—a top priority for our organization. We want to congratulate our partners at Vertex and thank all the patients who have participated in clinical trials. Your courage and commitment are inspiring.
Learn more here: bit.ly/48DuLTd
Alexandria Ratzki-LeeWing, PhD retweeted
Finally OP5 is ready to go with IPhones 📲
🚨 Breaking News! The Omnipod 5 App for iPhone is now available. Read all the details here: bit.ly/4fiJa9u #Omnipod5 #DiabetesTech
Alexandria Ratzki-LeeWing, PhD retweeted
simplicity takes CONFIDENCE, but it is so essential--if anything, I find it helps empower the audience TO ask questions. And, yes, I wish we could do away with the weird posturing of "oh, i barely practiced" rhetoric. 🙄
Alexandria Ratzki-LeeWing, PhD retweeted
A hypo is threatenin
My very life today
If I don't get some glucose
Ooh yeah, I'm gonna fade away
Low, children
It's just a shot away
#GimmeSugar
Alexandria Ratzki-LeeWing, PhD retweeted
Dr @AlexR_L is giving a fantastic talk with real-world data of the role of IAH on #hypoglycaemia rates in type 1 and type 2 #diabetes.
Don't miss out, come by Retiro Hall or join us virtually.
#EASD2024
Alexandria Ratzki-LeeWing, PhD retweeted
Prof Stephanie Amiel kicking off @IHSGonline symposium @EASDnews with @janespeight @MEvansCambridge @AlexR_L and me .. have we solved hypoglycaemia??
Alexandria Ratzki-LeeWing, PhD retweeted
Thank you to everyone who joined us at our 3rd #IHSGAdvances last week! The event had a fantastic turnout, with over 💯 attendees.
Become a member today and get exclusive access to all #hypoglycaemia content from Advances on demand: web.cvent.com/event/505fb300…
See you next year!
Alexandria Ratzki-LeeWing, PhD retweeted
Sure. A high quality diet is probably good for #T1D. But if you exercise a lot that same diet only has marginal benefits on #TIR. #Exercise improves TIR more than diet! More #T1DEXI data results now out cdn.nutrition.org/article/S2…
Alexandria Ratzki-LeeWing, PhD retweeted
Thanks to everyone who joined #IHSGAdvances!
We've had
-Exciting data updates📊
-Thought provoking discussions💬
-Variety of #hypoglycaemia topics🩸
A special thank you to all our speakers for taking the time to share their knowledge and expertise with the #diabetes community.
Alexandria Ratzki-LeeWing, PhD retweeted
Eid Mubarak from London, Ontario to all who celebrate. May this blessed period be full of kindness, charity, peace & joy. Of course our prayers go out to the Muslim children, brothers & sisters in Gaza & other parts of the world where atrocities are taking place. – at London, Ontario
Alexandria Ratzki-LeeWing, PhD retweeted
We’re keeping the presentations at #IHSGAdvances rolling as we now welcome lawyers Susan Toth (@ontcanlaw) and Andrew Camman, who will talk about human rights and employment law, as well as the legal aspects of creating #hypoglycaemia regulations.
Alexandria Ratzki-LeeWing, PhD retweeted
We have @epi_jblack presenting on #iNPHORM today!
Tomorrow, we have 3 more presentations on #iNPHORM in the Rapid Research Rounds session @judehzh @kiefernandes
Alexandria Ratzki-LeeWing, PhD retweeted
We’re live at #IHSGAdvances🎉
The conference is underway, and we’re excited to have the #hypoglycaemia community together for a great line up of talks and discussions.
Thanks to @BastiaanGalan and @AlexR_L for chairing the conference.
